Abbott LaboratoriesvsPro-Dex

ABT and PDEX stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$108.52

Value $189B

+1.12%
ABT's page

PDEX

Pro-Dex, Inc.

$65.96

Value $211M

+0.46%
PDEX's page

Abbott Laboratories (ABT) has a market value of $189B and Pro-Dex (PDEX) $211M. Over the last year, with dividends, ABT moved -13.9% and PDEX +105.5%. The P/E is 40.1 for ABT and 17.6 for PDEX. Dividend yield: ABT 2.32%, PDEX none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$189B

    PDEX$211M

    ABT is 892 times PDEX

  • Revenue, 12 months

    ABT$48.2B

    PDEX$80M

    ABT is 606 times PDEX

  • Net income, 12 months

    ABT$4.7B

    PDEX$12M

    ABT is 391 times PDEX

  • Operating margin

    ABT13.8%

    PDEX16.8%

    3.0 points apart

  • ROIC

    ABT6.3%

    PDEX17.4%

    11.1 points apart

  • P/E

    ABT40.1

    PDEX17.6

    ABT is 2.3 times PDEX

  • Dividend yield

    ABT2.3%

    PDEX0.0%

    2.3 points apart

  • 5-year return

    ABT-6.3%

    PDEX+184.7%

    191.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-6.3%

PDEX+184.7%

10020030020222023202420252026
Returns by period
PeriodABTWith dividendsPDEXWith dividends
1 year since November 14, 2025-13.9%Price -16.0%+105.5%Price +105.5%
3 years since November 16, 2023+16.6%+5.3% a yearPrice +9.5%+277.8%+55.7% a yearPrice +277.8%
5 years since November 15, 2021-6.3%-1.3% a yearPrice -15.2%+184.7%+23.3% a yearPrice +184.7%
10 years since November 16, 2016+231.4%+12.7% a yearPrice +174.7%+1,359.3%+30.7% a yearPrice +1,359.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesPDEXPro-Dex

Valuation

ABTPDEX
Valuation
Price$108.52$65.96
Market value$189B$211M
Enterprise value (EV)$215B$215M
P/E40.117.6
P/E, 5-year median33.714.2
P/B3.74.3
EV/EBIT32.416.0
Free cash flow yield3.6%5.1%

Results and growth

ABTPDEX
Results and growth
Revenue, 12 months$48.2B$80M
Net income, 12 months$4.7B$12M
Free cash flow, 12 months$6.8B$11M
Earnings per share, 12 months$2.69$3.63
Revenue growth, year on year5.7%16.5%
Revenue growth a year, past+5.1%over 5 years+15.3%over 5 years
EPS growth a year, past+8.3%over 5 years+21.3%over 5 years

Margins and returns on capital

ABTPDEX
Margins and returns on capital
Gross margin56.9%32.5%
Operating margin13.8%16.8%
Net margin9.8%15.1%
ROIC6.3%17.4%
ROE9.1%26.7%

Balance sheet

ABTPDEX
Balance sheet
Cash$4.3B$13M
Total debt$31.2B$19M
Net debt / EBITDA3.30.2
Interest cover6.7×15.4×

Dividends and buybacks

ABTPDEX
Dividends and buybacks
Dividend yield2.3%–
Dividend per share, 12 months$2.52–
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%1.6%
Shareholder yield2.8%1.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or PDEX

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or Pro-Dex?

By market value, Abbott Laboratories ($189B) is about 892.5 times Pro-Dex ($211M), at today's prices.

How did ABT and PDEX stock do over the last 10 years?

Since November 16, 2016, ABT's price moved +174.7% and PDEX's +1,359.3%. With dividends: ABT +231.4% (+12.7% a year), PDEX +1,359.3% (+30.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or PDEX?

The dividend yield at today's price is 2.32% for Abbott Laboratories and none for Pro-Dex. Over the last twelve months they paid $2.52 and – per share.

What is the P/E of ABT and PDEX?

At today's price, the P/E is 40.1 for ABT and 17.6 for PDEX. The median of the last five years was 33.7 and 14.2, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or Pro-Dex?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 15.1% for Pro-Dex, and the operating margin 13.8% and 16.8%. Revenue was $48.2B and $80M.

Which is the better investment, Abbott Laboratories or Pro-Dex?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.